Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 328 entries
View as:

S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone

Phase: N/A Priority: Normal
NCT ID: NCT00096213 Org: User:
Start: 12/31/04 End: 08/31/09 Due: 08/31/10

S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00109837 Org: User:
Start: 04/30/05 End: 11/30/14 Due: 11/30/15

S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00109850 Org: User:
Start: 05/31/05 End: 05/31/12 Due: 05/31/13

SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT00898872 Org: User:
Start: 03/31/93 End: 07/31/11 Due: 07/31/12

Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT04267913 Org: User:
Start: 09/05/20 End: 10/31/26 Due: 10/31/27

S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01809691 Org: User:
Start: 03/08/13 End: 10/31/27 Due: 10/31/28

S9912 Combination Chemo in Stage III Ovarian Cancer,

Phase: N/A Priority: Normal
NCT ID: NCT00003896 Org: User:
Start: 09/30/99 End: 02/29/08 Due: 02/28/09

S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00551460 Org: User:
Start: 11/15/07 End: 02/05/18 Due: 02/05/19

S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01925131 Org: User:
Start: 06/13/14 End: 01/01/23 Due: 01/01/24

Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

Phase: N/A Priority: Normal
NCT ID: NCT02785952 Org: User:
Start: 12/29/15 End: 04/01/26 Due: 04/01/27

SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002642 Org: User:
Start: 04/30/95 End: 07/31/04 Due: 07/31/05

SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01000558 Org: User:
Start: 03/31/05 End: 07/31/11 Due: 07/31/12

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05633615 Org: User:
Start: 06/12/23 End: 12/04/29 Due: 12/04/30

S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00075686 Org: User:
Start: 01/31/04 End: 04/30/09 Due: 04/30/10

S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00043082 Org: User:
Start: 08/31/02 End: 07/31/11 Due: 07/31/12

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003292 Org: User:
Start: 07/31/98 End: 01/31/04 Due: 01/31/05

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00016406 Org: User:
Start: 05/31/01 End: 02/29/12 Due: 02/28/13

S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00028769 Org: User:
Start: 12/31/01 End: 07/31/11 Due: 07/31/12

S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00124579 Org: User:
Start: 08/31/05 End: 06/30/10 Due: 06/30/11

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03091660 Org: User:
Start: 02/24/17 End: 06/15/26 Due: 06/15/27

S9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00031772 Org: User:
Start: 07/31/98 End: 11/30/03 Due: 11/30/04

S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003095 Org: User:
Start: 11/30/97 End: 02/28/01 Due: 02/28/02

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00070564 Org: User:
Start: 11/30/03 End: 01/31/27 Due: 01/31/28

S1119 Peruvian H. Pylori Water Contamination Study

Phase: N/A Priority: Normal
NCT ID: NCT01512875 Org: User:
Start: 12/31/11 End: 11/30/13 Due: 11/30/14

S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00109928 Org: User:
Start: 09/30/05 End: 04/30/14 Due: 04/30/15